Cargando…

Allium victorialis L. Extracts Promote Activity of FXR to Ameliorate Alcoholic Liver Disease: Targeting Liver Lipid Deposition and Inflammation

Allium victorialis L. (AVL) is a traditional medicinal plant recorded in the Compendium of Materia Medica (the Ming Dynasty). In general, it is used for hemostasis, analgesia, anti-inflammation, antioxidation, and to especially facilitate hepatoprotective effect. In recent years, it has received mor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cui, Zhen-Yu, Han, Xin, Jiang, Yu-Chen, Dou, Jia-Yi, Yao, Kun-Chen, Hu, Zhong-He, Yuan, Ming-Hui, Bao, Xiao-Xue, Zhou, Mei-Jie, Liu, Yue, Lian, Li-Hua, Zhang, Xian, Nan, Ji-Xing, Wu, Yan-Ling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531498/ https://www.ncbi.nlm.nih.gov/pubmed/34690775 http://dx.doi.org/10.3389/fphar.2021.738689

Ejemplares similares

Chemopreventive and Anticancer Activities of Allium victorialis var. platyphyllum Extracts
por: Kim, Hyun-Jeong, et al.
Publicado: (2014)

Beware of accidental ingestion of Colchicum autumnale mistaken for Allium victorialis
por: Nara, Tasuku, et al.
Publicado: (2023)

Transcriptome analysis and genetic diversity of Allium victorialis germplasms from the Changbai Mountains
por: Feng, Bo, et al.
Publicado: (2021)

Acanthoic Acid Can Partially Prevent Alcohol Exposure-Induced Liver Lipid Deposition and Inflammation
por: Yao, You-Li, et al.
Publicado: (2017)

The ameliorating effect of withaferin A on high-fat diet-induced non-alcoholic fatty liver disease by acting as an LXR/FXR dual receptor activator
por: Shiragannavar, Varsha D., et al.
Publicado: (2023)

Diammonium Glycyrrhizinate Ameliorates Obesity Through Modulation of Gut Microbiota-Conjugated BAs-FXR Signaling
por: Li, Yun, et al.
Publicado: (2021)

Shuangyu Tiaozhi decoction alleviates non-alcoholic fatty liver disease by improving lipid deposition, insulin resistance, and inflammation in vitro and in vivo
por: Yin, Guoliang, et al.
Publicado: (2022)

Effects of Poria cocos extract on metabolic dysfunction-associated fatty liver disease via the FXR/PPARα-SREBPs pathway
por: He, Jinbiao, et al.
Publicado: (2022)

Effects of Allium victorialis leaf extracts and its single compounds on aldose reductase, advanced glycation end products and TGF-β1 expression in mesangial cells
por: Kim, Young Sook, et al.
Publicado: (2013)

Corrigendum: Effects of Poria cocos extract on metabolic dysfunction-associated fatty liver disease via the FXR/PPARα-SREBPs pathway
por: He, Jinbiao, et al.
Publicado: (2023)

Obeticholic Acid Induces Hepatoxicity Via FXR in the NAFLD Mice
por: Lin, Chuangzhen, et al.
Publicado: (2022)

Gentiana scabra Restrains Hepatic Pro-Inflammatory Macrophages to Ameliorate Non-Alcoholic Fatty Liver Disease
por: Zheng, Yiyuan, et al.
Publicado: (2022)

A Quantitative Systems Pharmacology Model of Liver Lipid Metabolism for Investigation of Non-Alcoholic Fatty Liver Disease
por: Rieger, Theodore R., et al.
Publicado: (2022)

FXR and TGR5 Agonists Ameliorate Liver Injury, Steatosis, and Inflammation After Binge or Prolonged Alcohol Feeding in Mice
por: Iracheta‐Vellve, Arvin, et al.
Publicado: (2018)

Berberine Alleviates Non-alcoholic Steatohepatitis Through Modulating Gut Microbiota Mediated Intestinal FXR Activation
por: Shu, Xiangbing, et al.
Publicado: (2021)

Naturally Occurring TPE-CA Maintains Gut Microbiota and Bile Acids Homeostasis via FXR Signaling Modulation of the Liver–Gut Axis
por: Liu, Linlin, et al.
Publicado: (2020)

Doxofylline ameliorates liver fibrosis by regulating the ferroptosis signaling pathway
por: Xu, Lenan, et al.
Publicado: (2023)

Liver Capsule: FXR agonists against liver disease
por: Fuchs, Claudia D., et al.
Publicado: (2016)

Diosgenin Ameliorates Non-alcoholic Fatty Liver Disease by Modulating the Gut Microbiota and Related Lipid/Amino Acid Metabolism in High Fat Diet-Fed Rats
por: Zhou, Yuan, et al.
Publicado: (2022)

Magnesium Isoglycyrrhizinate Ameliorates Concanavalin A-Induced Liver Injury by Inhibiting Autophagy
por: Fan, Zihao, et al.
Publicado: (2022)

In vitro Antiproliferative and Apoptosis Inducing Effect of Allium atroviolaceum Bulb Extract on Breast, Cervical, and Liver Cancer Cells
por: Khazaei, Somayeh, et al.
Publicado: (2017)

Antiradical and Cytoprotective Properties of Allium nutans L. Honey Against CCL4-Induced Liver Damage in Rats
por: Sergazy, Shynggys, et al.
Publicado: (2021)

BCATc inhibitor 2 ameliorated mitochondrial dysfunction and apoptosis in oleic acid-induced non-alcoholic fatty liver disease model
por: Lu, Zhuo, et al.
Publicado: (2022)

Extracts of Dracocephalum tanguticum Maxim Ameliorate Acute Alcoholic Liver Disease via Regulating Transcription Factors in Mice
por: Guo, Min, et al.
Publicado: (2022)

Clinical Benefits of Golden-Antrodia Camphorata Containing Antroquinonol in Liver Protection and Liver Fat Reduction After Alcoholic Hepatitis
por: Yen, Yu-Ting, et al.
Publicado: (2022)

L-carnitine attenuated hyperuricemia-associated left ventricular remodeling through ameliorating cardiomyocytic lipid deposition
por: Yang, Yang, et al.
Publicado: (2023)

Veratrilla baillonii Franch Ameliorates Diabetic Liver Injury by Alleviating Insulin Resistance in Rats
por: Zhang, Zhi-Hao, et al.
Publicado: (2021)

Alcoholic liver steatosis in mice is aggravated by low-protein diet and reversed by FXR agonist
por: Lívero, Francislaine Aparecida dos Reis, et al.
Publicado: (2012)

Fatty liver diseases, bile acids, and FXR
por: Zhu, Yan, et al.
Publicado: (2016)

The Contribution of Dietary Fructose to Non-alcoholic Fatty Liver Disease
por: Yu, Siyu, et al.
Publicado: (2021)

Effects of cholesterol-lowering probiotics on non-alcoholic fatty liver disease in FXR gene knockout mice
por: Yang, Minghua, et al.
Publicado: (2023)

Lipophagy and Alcohol-Induced Fatty Liver
por: Yang, Li, et al.
Publicado: (2019)

LncRNA-AK012226 Is Involved in Fat Accumulation in db/db Mice Fatty Liver and Non-alcoholic Fatty Liver Disease Cell Model
por: Chen, Xingtian, et al.
Publicado: (2018)

Limonin Alleviates Non-alcoholic Fatty Liver Disease by Reducing Lipid Accumulation, Suppressing Inflammation and Oxidative Stress
por: Li, Yunjia, et al.
Publicado: (2022)

Gypenosides ameliorate ductular reaction and liver fibrosis via inhibition of hedgehog signaling
por: Hu, Yonghong, et al.
Publicado: (2022)

Natural Compounds: A Potential Treatment for Alcoholic Liver Disease?
por: Yan, Junbin, et al.
Publicado: (2021)

Systematic characterization of Puerariae Flos metabolites in vivo and assessment of its protective mechanisms against alcoholic liver injury in a rat model
por: Qu, Jialin, et al.
Publicado: (2022)

Dendrobium mixture ameliorates type 2 diabetes mellitus with non-alcoholic fatty liver disease through PPAR gamma: An integrated study of bioinformatics analysis and experimental verification
por: Zhuang, Shuting, et al.
Publicado: (2023)

Chlorogenic Acid Inhibits Lipid Deposition by Regulating the Enterohepatic FXR-FGF15 Pathway
por: Ye, Xiaolin, et al.
Publicado: (2022)

Untargeted and Targeted Metabolomics Reveal the Underlying Mechanism of Aspirin Eugenol Ester Ameliorating Rat Hyperlipidemia via Inhibiting FXR to Induce CYP7A1
por: Xiao-Rong, Lu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1d4hm98n48ot0smkr1jvimdp4b